KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Ionis Pharmaceuticals (IONS) Cost of Revenue (2018 - 2026)

Ionis Pharmaceuticals (IONS) has disclosed Cost of Revenue for 9 consecutive years, with $3.0 million as the latest value for Q1 2026.

  • For Q1 2026, Cost of Revenue rose 103.9% year-over-year to $3.0 million; the TTM value through Mar 2026 reached $17.4 million, up 65.55%, while the annual FY2025 figure was $15.9 million, 41.85% up from the prior year.
  • Cost of Revenue hit $3.0 million in Q1 2026 for Ionis Pharmaceuticals, down from $8.0 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $8.0 million in Q4 2025 and bottomed at $1.1 million in Q3 2024.
  • Average Cost of Revenue over 5 years is $3.1 million, with a median of $3.0 million recorded in 2026.
  • Year-over-year, Cost of Revenue tumbled 67.79% in 2023 and then soared 118.3% in 2025.
  • Ionis Pharmaceuticals' Cost of Revenue stood at $3.7 million in 2022, then fell by 16.93% to $3.1 million in 2023, then rose by 25.08% to $3.8 million in 2024, then soared by 107.75% to $8.0 million in 2025, then tumbled by 62.51% to $3.0 million in 2026.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $3.0 million, $8.0 million, and $2.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.